{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:18:12Z","timestamp":1787840292501,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"\n Background and Aims:<\/jats:title>\n Thrombosis is a major contributor to cardiovascular and cerebrovascular diseases. Despite the availability of anticoagulants and thrombolytic agents, their clinical use is often limited by adverse effects. Ginkgo biloba extract (GbE), a traditional herbal medicine, has shown promise in alleviating thrombosis, but its underlying mechanisms remain insufficiently understood. This study aimed to explore the antithrombotic effects and molecular mechanisms of GbE through network pharmacology and in vivo experiments.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n Online databases were utilized for identifying the GbE\u2019s active components and target genes, accompanied by thrombosis-related targets. Functional enrichment analyses, including Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis, were performed. A drug-active component-target gene-signaling pathway network and a protein-protein interaction (PPI) network were constructed to determine core target genes and pathways.\n In vivo<\/jats:italic>\n , a deep vein thrombosis (DVT) model was established by ligating the inferior vena cava in male Sprague-Dawley rats. Hematoxylin and eosin staining was adopted for evaluating the vascular endothelial structure. The levels of cyclic guanosine monophosphate (cGMP), prostaglandin I2 (PGI2), nitric oxide (NO), and fibrinogen (FIB) were measured, accompanied by the activated partial thromboplastin time (APTT), thrombin time (TT), and prothrombin time (PT). Western blot analysis was performed to examine the PI3K\/AKT pathway-related protein expression.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n GbE comprised 27 active components with 4727 target genes and 2462 thrombosis-related targets, with 974 shared targets, including AKT1, ALB, GAPDH, TNF, and IL6, enriched in PI3K-AKT and AGE-RAGE pathways. Molecular docking indicated strong binding of GbE\u2019s main components to core targets.\n In vivo<\/jats:italic>\n , GbE significantly relieved vascular lesions of DVT rats; reduced thrombotic wet weight; increased NO, cGMP, and PGI2 levels; decreased FIB; and prolonged APTT, PT, and TT (\n P<\/jats:italic>\n < 0.05). Additionally, Western blot highlighted the suppressed p-PI3K\/PI3K and p-AKT\/AKT ratios in DVT rats.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n GbE alleviates thrombosis by increasing antithrombotic factors and reducing coagulation, potentially via downregulating the PI3K\/AKT signaling. Future studies should focus on long-term clinical trials and broader animal models to further validate GbE\u2019s therapeutic potential and explore other molecular mechanisms.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/njcp.njcp_770_24","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T01:01:21Z","timestamp":1748998881000},"page":"624-632","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Antithrombotic Effect of Ginkgo Biloba Extract: A Study Based on Network Pharmacological Analysis and In vivo Experiments"],"prefix":"10.4103","volume":"28","author":[{"given":"H","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Suzhou BOE Hospital, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Suzhou Kowloon Hospital, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Health Management Certer, Suzhou Kowloon Hospital, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Yang","sequence":"additional","affiliation":[{"name":"SysCan BioTech (SuZhou) CO., LTD, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Liao","sequence":"additional","affiliation":[{"name":"Guangzhou Yujia Biotechnology Co., Ltd, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Health Management Certer, Suzhou Kowloon Hospital, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"e32082.","DOI":"10.1097\/MD.0000000000032082","article-title":"Risk factors of cardiovascular and cerebrovascular diseases in young and middle-aged adults: A meta-analysis","volume":"101","author":"Wu","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.2174\/1381612825666190925163827","article-title":"A brief review of cardiovascular diseases, associated risk factors and current treatment regimes","volume":"25","author":"Flora","year":"2019","journal-title":"Curr Pharm Des"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"358","DOI":"10.35772\/ghm.2020.01113","article-title":"Cardiovascular disease, a major global burden: Epidemiology of stroke and ischemic heart disease in Japan","volume":"3","author":"Iso","year":"2021","journal-title":"Glob Health Med"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1024\/0301-1526\/a001145","article-title":"Epidemiology of deep vein thrombosis","volume":"53","author":"Wolf","year":"2024","journal-title":"Vasa"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-981-15-2517-9_4","article-title":"Antithrombotic Drugs-Pharmacology and Perspectives","volume":"1177","author":"Li","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/17474086.2021.1905512","article-title":"Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment","volume":"14","author":"Hvas","year":"2021","journal-title":"Expert Rev Hematol"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.2174\/0109298673268452231108061008","article-title":"Natural phenolic compounds with antithrombotic and antiplatelet effects: A drug-likeness approach","volume":"31","author":"Fernandes","year":"2024","journal-title":"Curr Med Chem"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"e14419.","DOI":"10.1111\/jfbc.14419","article-title":"Molecular mechanism of Ginkgo biloba in treating type 2 diabetes mellitus combined with non\u2010alcoholic fatty liver disease based on network pharmacology, molecular docking, and experimental evaluations","volume":"46","author":"Xu","year":"2022","journal-title":"J Food Biochem"},{"key":"R9-20260422","first-page":"426","article-title":"Research progress of pharmacological effects and clinical application of Ginkgo biloba extract","volume":"44","author":"Pengfei","year":"2017","journal-title":"Liaoning J Tradit Chin Med"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.2147\/DDDT.S318515","article-title":"The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation","volume":"15","author":"Ke","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"272.","DOI":"10.3390\/ph15050572","article-title":"Network pharmacology approach for medicinal plants: Review and assessment","volume":"15","author":"Noor","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jss.2015.11.008","article-title":"Danhong huayu koufuye prevents deep vein thrombosis through anti-inflammation in rats","volume":"201","author":"Zhang","year":"2016","journal-title":"J Surg Res"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"854249.","DOI":"10.3389\/fphar.2022.854249","article-title":"Neuroprotective effects of quercetin on ischemic stroke: A literature review","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"154674.","DOI":"10.1016\/j.phymed.2023.154674","article-title":"The grading quality markers identification of Panax notoginseng under the guidance of traditional experience using untargeted metabolomics and anti-myocardial ischemia evaluation of zebrafish","volume":"111","author":"Li","year":"2023","journal-title":"Phytomed"},{"key":"R15-20260422","first-page":"3717","article-title":"Study on traditional effect of Panax notoginseng based on network pharmacology","volume":"51","author":"Wu","year":"2020","journal-title":"Zhongcaoyao"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/jth.15844","article-title":"The NO\/ cGMP\/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders","volume":"20","author":"Degjoni","year":"2022","journal-title":"J Thromb Haemost"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00424-018-2229-6","article-title":"Endothelial prostacyclin protects the kidney from ischemia-reperfusion injury","volume":"471","author":"Cao","year":"2019","journal-title":"Pflugers Arch"},{"key":"R18-20260422","first-page":"593","article-title":"Roles of PI3K\/AKT signaling pathways on neuregulin1-facilitated pain in rats","volume":"16","author":"Jing-Jing","year":"2016"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1182\/blood-2012-10-461897","article-title":"PDK1 regulates platelet activation and arterial thrombosis","author":"Chen","year":"2013","journal-title":"Blood"}],"updated-by":[{"DOI":"10.4103\/njcp.njcp_877_25","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_770_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:19:38Z","timestamp":1787836778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_770_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_770_24","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2024-11-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}